Gene Panel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Component (Test Kits v/s Testing Services), By Technique (Amplicon Based Approach v/s Hybridization Based Approach), By Design (Predesigned Gene Panel v/s Customized Gene Panel), By Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others), By End User (Academic & Research Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies), By Region and Competition

Global gene panel market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing prevalence of genetic disorders like down syndrome, sickle cell disease, tay-saches disease and others. Due to increasing healthcare awareness among the population and rising demand for early diagnosis, lots of couples opt for genetic testing before baby planning or during the pregnancy, further boosting the market over the forecast period. Increasing application of gene panel owing to the low cost of the technique, and fast and accurate testing are expected to propel the market growth. Besides, improving healthcare infrastructure coupled with growing investments in research & development related to gene panel is further expected to create lucrative opportunities for the market growth in the coming years. One of the biggest challenges of gene panel testing is the interpretation of data. Gene panels can identify a large number of genetic variants, and it can be difficult to determine which variants are clinically significant and which are benign. This can lead to false positives, false negatives, and uncertainty about the clinical significance of identified variants. There is a lack of standardization in gene panel testing, with different laboratories using different panels, platforms, and analytical methods. This can lead to variability in results, making it difficult to compare results across different laboratories. Gene panels have continued to expand to include more genes and genetic variants. This allows for more comprehensive testing and improved identification of disease-causing mutations. AI and machine learning technologies have been applied to gene panel testing to improve the accuracy and efficiency of data analysis. These tools can help to identify disease-causing mutations more accurately and efficiently than traditional methods. Integration of gene panel testing with electronic health records (EHRs) can improve the efficiency and accuracy of diagnosis and treatment. This integration allows for seamless sharing of genomic data with healthcare providers and can help to guide personalized treatment decisions. Gene panels offer several advantages over traditional genetic testing methods. First, they allow for a more comprehensive analysis of genes associated with a particular disease or condition. This targeted approach can lead to a more accurate diagnosis and more effective treatment options. Second, gene panels are less expensive than whole-genome sequencing, making them more accessible to patients.

Growing Incidence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, congenital diseases, heart attack, arthritis are expected to growth of the gene panel market during the forecast period. Increasing disorder because of genetic mutation demand for gene panel testing. It is a diagnostic technique that analyses many genes for cancer associated alterations at the same time. High demand for gene panels by the major key players to develop and launch cancer therapy is expected to growth of the gene panel market over the forecast period.  According to the global cancer observatory, around 19,292,789 new cancer cases were reported worldwide. Out of these, 9,227,484 new cancer cases were reported in females while the number of new cancer cases reported in men were around 10,065,305. The growing prevalence of cancer will increase the demand for gene panel. Given the high cost, genetic testing is usually only carried out on patients who are at a high risk of developing specific types of cancer because of their heredity disorder. This may include lifestyle factors such as smoking, leading unhealthy lifestyle, reduced physical activity and alcohol consumption. According to World Health Organization (WHO), around 295 000 new-borns die within 28 days of birth every year, worldwide, due to congenital anomalies. The prevalence of genetic disorders, such as cancer, cardiovascular disease, and rare genetic disorders, is increasing globally. Gene panel testing enables the detection of genetic mutations associated with these disorders, providing a more precise diagnosis and treatment plan. There are several factors that contribute to the increased prevalence of genetic disorders. Some genetic disorders are caused by inherited mutations, which are passed down from parent to child. As the population grows, the frequency of these inherited mutations can increase, leading to a higher prevalence of genetic disorders. Environmental factors, such as exposure to radiation, chemicals, or certain viruses, can cause genetic mutations that increase the risk of developing genetic disorders.

Rising demand for personalized medicine

Personalized medicine aims to provide targeted therapies based on an individual's genetic makeup. Gene panel testing allows for the identification of genetic mutations that may respond to specific therapies, leading to more effective treatment outcomes. Personalized medicine is needed for disease control because it allows for a more precise and individualized approach to treatment. Traditional approaches to medicine are often based on a one-size-fits-all approach, where patients with the same disease receive the same treatment, regardless of their individual genetic and environmental factors. However, personalized medicine recognizes that each individual is unique, and their response to treatment may vary based on their specific genetic makeup, lifestyle, and environmental factors. It can lead to more effective treatment outcomes by tailoring treatments to an individual's specific needs. For example, in cancer treatment, personalized medicine involves identifying specific genetic mutations in a patient's tumor and targeting those mutations with specific therapies, rather than using a broad treatment approach that may not be as effective. In addition to improving treatment outcomes, personalized medicine can also help to reduce healthcare costs by avoiding treatments that are unlikely to be effective and reducing the need for trial-and-error treatments.

Growing research activities in genomics

The increasing focus on genomics research has led to a surge in demand for gene panel testing, as it enables researchers to investigate multiple genes and pathways simultaneously. This has led to the development of new gene panels and expanded applications for existing panels. There are several reasons why research activities in genomics have increased in recent years. Genomics research has the potential to uncover new insights into human biology, disease, and evolution. This has led to increased interest in genomics research from both academic and industry researchers. The development of personalized medicine, which uses genomic information to tailor treatments to individual patients, has created a strong demand for genomics research. Researchers are working to identify new genetic targets for personalized treatments and to develop new diagnostics based on genomic data. Genomics research is a multidisciplinary field that involves collaboration across many different areas of expertise, including genetics, biology, computer science, and medicine. This has led to increased collaboration between researchers from different fields, leading to new discoveries and innovations. Many governments around the world have increased funding for genomics research in recent years, recognizing the potential benefits of genomics research for human health and disease.

Technological Advancements

Increasing demand for advanced medical testing, along with personalized medicines in clinical diagnosis will create lucrative opportunities for the market growth in the forecast period. Currently, genetic disorders are common in geriatric population, which supports the gene panel market growth extensively. Many global companies are focusing on developing new and advanced gene panels which is further expected to propel the market growth over the coming years. Increasing initiative and investment by many private and government organizations for developing new technology is a major factor that boost the market growth. Birth defects affect 1 in every 33 babies born in the United States each year which translates into about 120,000 babies.

Recent Development

• In 2021, QIAGEN launched a suite of gene panels for targeted sequencing applications, including panels for cancer research, immuno-oncology, and inherited disease research. These panels use a proprietary technology to improve the sensitivity and specificity of targeted sequencing.
• In 2019, Illumina launched TruSight Oncology 500, a comprehensive gene panel for the detection of somatic mutations in cancer. This panel includes genes associated with a wide range of cancer types and can be used for both research and clinical applications.
• In 2019, Thermo Fisher Scientific launched a suite of on-demand gene panels for targeted sequencing applications. These panels allow researchers to create custom gene panels tailored to their specific research needs.

Download Free Sample Report

Market Segmentation

The global gene panel market can be segmented by component, by technique, by design, by application, by end user and by region. Based on component, the market can be divided into Test Kits and Testing Services. Based on technique, the market can be divided into Amplicon Based Approach and Hybridization Based Approach. Based on design, the market can be divided into Predesigned Gene Panel and Customized Gene Panel. Based on Application, the market can be segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others. Based on end user, the market can be differentiated into Academic & Research Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the Global Gene Panel Market on account of growing demand for gene panel technique for rising cases of cancer across the globe. A little over 1.9 million new cancer cases is expected to be diagnosed in the United States in 2022, according to the 2022 Cancer Facts & Figures report from the American Cancer Society (ACS).

Market Players

Illumina, Inc., Agilent Technologies, Inc., Thermo Fischer Scientific, Inc., QIAGEN NV, Eurofins Scientific SE, Foundation Medicine Inc., Guardant Health, Inc., Myriad Genetic Laboratories Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG are some of the leading players operating in the Global Gene Panel Market.

Report Scope:

In this report, global gene panel market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

        ·         Gene Panel Market, By Component:

o    Test Kits

o    Testing Services

        ·         Gene Panel Market, By Technique:

o   Amplicon Based Approach

o   Hybridization Based Approach

        ·         Gene Panel Market, By Design:

o   Predesigned Gene Panel

o   Customized Gene Panel

        ·         Gene Panel Market, By Application:

o   Cancer Risk Assessment

o   Diagnosis of Congenital Diseases

o   Pharmacogenetics

o   Others

        ·         Gene Panel Market, By End User:

o   Academic & Research Institutes

o   Hospital & Diagnostic Laboratories

o   Pharmaceutical & Biotechnology Companies

        ·         Gene Panel Market, By Region:

o    North America

§  United States

§  Canada

§  Mexico

o    Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o    Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o    South America

§  Brazil

§  Argentina

§  Colombia

o    Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Gene Panel Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Gene Panel Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]